Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Cannabis, or “marijuana,” has been employed in various forms throughout the millennia for both symptomatic and prophylactic treatment of migraine. This document examines its history of medicinal use by smoking and other methods in ancient cultures, including the Chinese, Indian, Egyptian, Assyrian, Greek and Roman, as well as in the Islamic world, and its subsequent adoption by Renaissance and Industrial Age Europeans. The most prominent physicians of the age in the century between 1842 and 1942 preferred cannabis to other preparations in migraine treatment, and it remained part of Western pharmacopoeias for this indication throughout the period. The writings of this era are examined in great detail in an effort to emphasize useful medical documentation that has subsequently been forgotten. In modern times, ethnobotanical and anecdotal references continue to support the efficacy of cannabis for headache treatment, while biochemical studies of THC and anandamide have provided scientific justification for its use via anti-inflammatory, serotonergic and dopa-minergic mechanisms, as well as by interaction with NMD A and endogenous opioid systems. These are examined in detail. The author feels that this collective evidence supports the proposition that experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · cited 1×
“The dearth of cannabinoid receptors in the area postrema (Herkenham et al. 1990; Fride and Mechoulam 1996) coupled with the clinical effectiveness of cannabinoids as antiemetics (Abrahamov and Mechoulam 1995), support such an alternative mechanism.”
BackgroundGlass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052 · cited 1×
“The PAG is a putative migraine generator area (Goadsby and Gundlach 1991; Raskin 1988), and is integral to ascending and descending pain pathways, fear and anxiety (Behbehani 1995). Weiller et al. (1995) examined migraineurs during attacks with positron emission tomography (PET), demonstrating various sites of regiona…”
BackgroundFunctional characteristics of the midbrain periaqueductal gray.
Behbehani, M. M. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00009-k · Cited by 879
Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants
Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850
An analgesia circuit activated by cannabinoids
Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L. (1998) · Nature · doi:10.1038/26481 · Cited by 411 · cited 1×
“Meng’s results are discussed above (Meng et al. 1998).”
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378 · cited 1×
“A similarly composed research group compared the analgesic effect of THC was compared to codeine (Noyes et al. 1975).”
ResultProstaglandins and cannabis—II inhibition of biosynthesis by the naturally occurring cannabinoids
Burstein, S., Levin, E., & Varanelli, C. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90158-5 · Cited by 84 · cited 1×
“Burstein et al. (1973) demonstrated that THC and other cannabinoids could inhibit prostaglandin E-2 synthesis, and that the aromatic moiety seemed to be the critical portion.”
BackgroundCannabinoids: The separation of central from peripheral effects on a structural basis
Evans, F. (1991) · Planta Medica · doi:10.1055/s-2006-960231 · Cited by 76
Cited by
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094
“Several historic reviews have been written on Cannabis use as a therapeutic drug, the most recent of which are those by Russo (2001, 2002) and ElSohly (2002).”
BackgroundAgonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
“Noteworthy in this regard is serotonin (5-hydroxytryptamine; 5-HT), which is known to be involved in many of the same processes important to cannabis’s actions (12,13) such as relief of anxiety, pain, the complex processes of 1 Skaggs School of Pharmacy, The University of Montana,”
BackgroundSelf-citationHistory of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 621
Self-citationRusso, E., & Guy, G. W. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 610
Self-citationCannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
McPartland, J. M., & Russo, E. B. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n03_08 · Cited by 321
Self-citation
Metadata
- Authors
- Russo, E.
- Venue
- Journal of Cannabis Therapeutics
- Publisher
- Informa UK Limited
- Published
- 2001-03
- Volume
- 1
- Issue
- 2
- Pages
- 21-92
- ISSN
- 1529-9775 (ISSN-L)
- OpenAlex
- W1683887674
- Cited by
- 66
- References
- 8
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment. https://app.cochat.ai/papers/10.1300/j175v01n02_04
- The paper
- Russo, E. (2001). Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment. Journal of Cannabis Therapeutics. https://doi.org/10.1300/j175v01n02_04
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.